Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Join
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Join
FREE
Edition
European
US
Oncology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Hydrogel Urothelial Cancer Therapies
10
Mins
June 2025
Urological cancers are malignancies that affect the organs of the urinary system and male reproductive system. Of these, bladder cancer…
Read more
7
Mins
7 Aug 2023
PTEN Loss causing Dabrafenib and Trametinib Resistance in Epithelioid Glioblastoma
This case report explores a rare and aggressive variant of glioblastoma that is common in children and young adults…
8
Mins
26 Jul 2023
Interview: Kelly Hirko
My interest in cancer research was sparked during my experience in the Undergraduate Research Opportunity Program (UROP) as an…
10
Mins
16 Mar 2023
The Role of Granulocyte-Colony Stimulating Factor Biosimilars for Supportive Cancer Care: A Year in Review
Chemotherapy-induced neutropenia is a frequent, severe, adverse haematological complication of myelosuppressive and immunosuppressive cytotoxic chemotherapy treatment.
11
Mins
14 Feb 2023
A Review of the Latest Advancements in Ovarian Cancer Care Featured at ESMO 2022
Ovarian cancer is the seventh most commonly diagnosed cancer among females and the most lethal gynaecologic malignancy globally because of its vague presentation, insidious nature, recurrence, and drug resistance.
6
Mins
6 Feb 2023
Marantic Endocarditis and Lung Adenocarcinoma with Brain Metastasis
This case report aims to unveil the possible differentials and processes involved in the diagnosis of marantic endocarditis…
7
Mins
18 Jan 2023
Radical Radiotherapy in Sinonasal Myopericytoma
The current study reports a case of extended maxillary sinus myopericytoma, diagnosed following the development of an early bulky recurrence 3 months after surgical excision…
9
Mins
8 Dec 2022
EGFR-Mutant Non-small Cell Lung Cancer: Future Perspectives
This review focuses on the state-of-the-art EGFR-TKIs in the treatment of metastatic NSCLC…
11
Mins
5 Dec 2022
Targeting Fibroblast Growth Factor Receptor Alterations in Cholangiocarcinoma and Other Solid Tumours: A New Frontier in Personalised Medicine
Cholangiocarcinoma (CCA) is a cancer of the bile duct with poor prognosis and increasing incidence. Filippo de Braud gave an overview of CCA and its classification and highlighted key unmet needs in both diagnosis and treatment. Juan Valle explained that intrahepatic CCA (iCCA) accounts for 11% of the entire cancer of unknown primary (CUP) population, as well as 33% of patients with liver-inclusive disease.
Loading posts...
« Previous
1
…
4
5
6
7
8
…
29
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View